[Contribution of CB1 receptor in the DRG for nociception and its use for pain treatment].
Fumimasa
F
Amaya
D000818:Animals; D001095:Arachidonic Acids / Q000008:administration & dosage*; D002186:Cannabinoids / Q000627:therapeutic use; D005727:Ganglia, Spinal / Q000378:metabolism*; D015870:Gene Expression; D006801:Humans; D010146:Pain / Q000209:etiology* / Q000378:metabolism; D059408:Pain Management; D012333:RNA, Messenger / Q000378:metabolism; D043884:Receptor, Cannabinoid, CB1 / Q000819:agonists* / Q000235:genetics / Q000502:physiology*
D001095:Arachidonic Acids; D002186:Cannabinoids; D012333:RNA, Messenger; D043884:Receptor, Cannabinoid, CB1; C119325:arachidonyl-2-chloroethylamide